|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
4 February 2013 |
|
Main ID: |
NCT00263432 |
|
Date of registration:
|
04/12/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes
|
|
Scientific title:
|
Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes |
|
Date of first enrolment:
|
August 2011 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00263432 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Karl Fredrik Almqvist, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
fredrik.almqvist@UGent.be |
|
Affiliation:
|
|
|
|
Name:
|
Karl Fredrik Almqvist, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
fredrik.almqvist@UGent.be |
|
Affiliation:
|
|
|
|
Name:
|
Karl Fredrik Almqvist, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital, Ghent |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Important cartilage injury in the knee
Exclusion Criteria:
- Important axis deviation
- Inflammatory joint disorder
- Severe obesity
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cartilage Injuries in the Human Knee
|
|
Intervention(s)
|
|
Procedure: Human allogenic chondrocytes
|
|
Primary Outcome(s)
|
|
Healing of the cartilage injuries
[Time Frame: After 2 years]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|